Edesa Biotech (EDSA) Non Operating Income (2013 - 2026)
Edesa Biotech (EDSA) posted Non Operating Income of $111,938 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 27.4% from $154,279 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Non Operating Income (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Edesa Biotech was $601,821, up 14.1% year-over-year; for FY2025 (ended Sep 30, 2025), it was $726,843, down 14.0% from FY2024.
- Annual Non Operating Income shows a five-year compound annual growth rate of 81.0% (FY2020 to FY2025).
- In prior fiscal years, Edesa Biotech's Non Operating Income was $845,499 in FY2024 (-0.4%), $849,143 in FY2023 (+3.2%), $822,666 in FY2022 (-92.0%) and $10.34 million in FY2021.
- Quarterly Non Operating Income has run from a low of $6,715 in fiscal Q2 2022 to a high of $1.8 million in fiscal Q4 2021 over five years.
- On a year-over-year basis, Non Operating Income increased in two of the last seven quarters, with growth averaging 30.4%.
- The strongest year-over-year quarter for Non Operating Income in the past five years was fiscal Q3 2023, with growth of 654.9%; the weakest was fiscal Q2 2022, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Edesa Biotech | 40.56 Mn | 40.56 Mn | - | 111,938.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111,938.00 |
| Dec 31, 2025 | 93,714.00 |
| Sep 30, 2025 | 241,890.00 |
| Jun 30, 2025 | 154,279.00 |
| Mar 31, 2025 | 49,238.00 |
| Dec 31, 2024 | 281,436.00 |
| Sep 30, 2024 | 42,345.00 |
| Jun 30, 2024 | 264,233.00 |
| Mar 31, 2024 | 359,943.00 |
| Dec 31, 2023 | 178,978.00 |
| Sep 30, 2023 | 649,320.00 |
| Jun 30, 2023 | 79,303.00 |
| Mar 31, 2023 | 77,032.00 |
| Dec 31, 2022 | 43,488.00 |
| Sep 30, 2022 | 22,400.00 |
| Jun 30, 2022 | 10,505.00 |
| Mar 31, 2022 | 6,715.00 |
| Dec 31, 2021 | 783,046.00 |
| Sep 30, 2021 | 1.80 Mn |
| Jun 30, 2021 | 1.31 Mn |
API Access
Edesa Biotech Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();